Disparities in availability of new cancer drugs worldwide: 1990-2022
Introduction Despite progress in the development of new cancer drugs, concerns about equity of access remain. This study aimed to examine the availability and timeliness of availability of new cancer drugs around the globe over the past three decades and their associations with country characteristi...
Saved in:
| Main Authors: | Meng Li, Qiushi Chen, DukHee Ka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-10-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/9/9/e015700.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Russia-Ukraine war reduced food production and exports with a disparate geographical impact worldwide
by: Nan Jia, et al.
Published: (2024-12-01) -
Respiratory syncytial virus burden in children under 2 years old in understudied areas worldwide: gap analysis of available evidence, 2012–2022
by: Rodrigo Sini de Almeida, et al.
Published: (2024-11-01) -
The environmental price of socio-economic development: Worldwide trends from 1990 to 2016
by: Katja VINTAR MALLY
Published: (2022-02-01) -
Burden of thyroid cancer in China and worldwide from 1990 to 2021: observation, comparison, and forecast from the Global Burden of Disease Study 2021
by: Ziang Meng, et al.
Published: (2024-12-01) -
Global burden, trends, and disparities in kidney cancer attributable to smoking from 1990 to 2021
by: Siyu Han, et al.
Published: (2025-01-01)